
Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
Demetra Antimisiaris, PharmD, CGP, FASCP, discusses the potential complications that can arise from improper renal dosing.
Demetra Antimisiaris, PharmD, CGP, FASCP, discusses the potential complications that can arise from improper renal dosing.
This video was recorded at ASCP's Annual Meeting and Exhibition in Las Vegas, Nevada in October 2015.






